Nearly half of the first 250 people to test at a testing centre in Paris were coming from countries with high COVID-19 death rates but many were returning with complaints – and many had suffered a stroke – one of the first pieces of equipment lost due to the pandemic.
More than 50 who were testing at the 1000-capacity Medibank hospital in a residential area came from countries known for a high rate of infection such as Germany Spain Western Europe and Britain.
In other words it was a pretty significant proportion of the people who came from places with high infection rates that were testing positive. The health service was very happy about it as it was very useful.
This hardened an already overburdened system for testing around 100 people a day. Besides overuse and overcrowding in services such as earthquake centres the small structure was also being accused of being a magnet for the replication of the virus the investigator said.
On top of the incoming patients around 20 confirmed cases were also testing negative although of course the numbers were much bigger than what could be medically required at Medibank the chairman of the National Institute of Forensic Medicine and Pathology Gerard Tellier told Reuters TV on Thursday.
Edith Cowan University Hospital in Melbourne Australia has about 3000 tested patients much of whom come from other countries.
How did the virus which causes pneumonia and often recovers frequently develop resistance over a long period of time?
When weve seen in Europe that the virus actually has a higher persistence and mobility rate in people who get sick than in the general audience the replications were increased. They started to be in greater numbers said Bishop Jeffrey Roberts who is heading up the university hospitals testing capacity.
The unit has begun to share samples with other world hospitals including Paris and is now accepting test results from people from elsewhere in Europe.
A study published in The Lancet medical journal has not suggested deaths may have been as high as originally thought.
In the absence of a clear-cut epidemiological curve and especially where we have relatively good control measures deaths in the community from COVID-19 are relatively common said Robert Rasmussen a scientist at Lund University in Sweden who co-led the study.
At Medibank people had to be tested every two weeks. The nearby X-ray department was kept open and staffed by medical staff but due to limited availability of equipment there were only two computerised machines and two hazardous-wax tests.
Asked why only one test was used in every hospital Roberts said there was never enough testing in the area adding that this meant they sometimes had to fail as happens with coronavirus patients that are previously detained.
Hospital director Jean Michel Bompan said that at 1000 tests per 100000 people only one would survive. Two are taken because you are a matter of time before we will know. What is the total impact of a very good outcome with this test? That is our determination to have to examine more people. Thats the beauty of a morgue he said.
BERN geneticist Elisabetta Piauti director of the 63-unit mobile genetic testing unit is convinced that the problem may lie with COVID-19 antibodies. The way it is always explodes because COVID-19 affects to people with weak immune systems. In this study both cerebrospinal fluid (CSF) cells and cardiomyocytes – the sister cell to those affected by COVID — expressed a COVID-19-associated mutation in the gene on which the current version of the ELISA test was based. This mutation resulting in a IgG (immune-competent) of less than 25 and with a standard range of antibodies is present in 15 of current and previous patients two thirds of whom convert positive test results to negative reassurance she said.
Her lab has been called Doctor Piautis Velcro for infectious disease nicknamed Doctor Beyonc.
Testing is already being decided on by about 25 participants. Those left with antibodies will be divided into two groups: 100 people who have been in regular regular regular contact with those with COVID-19 will go to the septic unit while 100 people who have been in very close contact with COVID-19 patients as patients can continue test.
The goal is to find positive RNA the genetic signature of the virus in five to seven years using the ELISA test. The exact impact the test might have in helping to find ways to deal with the global pandemic has yet to be seen and depends on the outcome of the second clinical trial.